Covid-19 vaccine approvals and stock market returns: the case of Chinese stocks

From MaRDI portal
Revision as of 00:15, 2 February 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:2158358